2005
DOI: 10.1016/j.fct.2005.01.020
|View full text |Cite
|
Sign up to set email alerts
|

Safety assessment of esters of p-hydroxybenzoic acid (parabens)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
541
3
30

Year Published

2008
2008
2015
2015

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 855 publications
(582 citation statements)
references
References 137 publications
8
541
3
30
Order By: Relevance
“…The phenols evaluated in this study or, in the case of the dichlorophenols, their parent compounds, rapidly metabolize in the body after exposure through Phase I and/or Phase II biotransformations before excretion in the urine (5,(42)(43)(44)(45). Both conjugated and free species have been used as valid biomarkers of exposure to the parent compounds (6,9,46).…”
Section: Discussionmentioning
confidence: 99%
“…The phenols evaluated in this study or, in the case of the dichlorophenols, their parent compounds, rapidly metabolize in the body after exposure through Phase I and/or Phase II biotransformations before excretion in the urine (5,(42)(43)(44)(45). Both conjugated and free species have been used as valid biomarkers of exposure to the parent compounds (6,9,46).…”
Section: Discussionmentioning
confidence: 99%
“…Many cosmetic products, including antiperspirants, contain parabens that can be dermally absorbed. Parabens have estrogen-like properties in cell cultures, causing proliferation of estrogen-responsive cells, although they are thousands of times less potent than naturally-occurring estrogen in this regard [164][165][166]. Parabens were found to activate both estrogen receptors, ER-α and ER-β, with similar or stronger effect versus ER-β receptors [165,167,168].…”
Section: Parabensmentioning
confidence: 96%
“…Parabens were found to activate both estrogen receptors, ER-α and ER-β, with similar or stronger effect versus ER-β receptors [165,167,168]. The ability of parabens to transactivate the ER in vitro increases with alkyl tail bulkiness [166]. Competitive inhibition of 17β-estradiol binding to estrogen-dependent MCF7 cell ERs could be detected at 1,000,000-fold molar excess of butylparaben (BuP, 86%), propylparaben (PrP, 77%), ethylparaben (EtP, 54%) and methylparaben (MeP, 21%).…”
Section: Parabensmentioning
confidence: 99%
See 1 more Smart Citation
“…Other than weak estrogenic activity (these parabens are 410 000-fold less potent than 17b-estradiol), neither E-4HB nor P-4HB has known biological activity and neither are carcinogenic nor teratogenic. 22 E-4HB nor P-4HB are small and inexpensive. Additionally, as benzoates are easily synthetically modified, the parabens lend themselves to combinatorial chemistry and can be paired with libraries of BXRb mutants to create new orthogonal ligand-receptor pairs or increase affinity of the currently recognized ligands.…”
Section: Introductionmentioning
confidence: 99%